Skip to main content

Table 1 Demographic and laboratory parameters of the studied groups

From: Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment

Variables

HCC (N = 30)

Cirrhosis (N = 30)

P value

Age (years)

 Mean ± SD

57.5 ± 6.3

54.4 ± 8.7

^0.112

 Range

46.0–68.0

42.0–68.0

BMI (kg/m2)

 Mean ± SD

24.8 ± 2.3

24.9 ± 3.0

^0.885

 Range

22.0–29.0

20.0–29.0

Gender (n, %)

 Male

22 (73.3%)

18 (60.0%)

#0.273

 Female

8 (26.7%)

12 (40.0%)

Child score (n, %)

 A

25 (83.3%)

20 (66.7%)

#0.136

 B

5 (16.7%)

10 (33.3%)

MELD score

 Mean ± SD

7.8 ± 4.9

7.7 ± 5.3

^0.967

 Range

1.0–18.3

1.0–20.1

Hemoglobin (g/dL)

 Mean ± SD

12.0 ± 1.6

12.3 ± 1.0

^0.429

 Range

9.5–14.0

10.8–14.2

TLC (× 103/mL)

 Mean ± SD

6.7 ± 2.0

6.6 ± 1.4

^0.754

 Range

3.8–9.7

4.7–9.3

Platelets (× 103/mL)

 Mean ± SD

173.2 ± 38.4

175.9 ± 44.3

^0.802

 Range

89.0–258.0

112.0–246.0

AST (IU/L)

 Mean ± SD

50.9 ± 28.3

30.8 ± 14.8

^0.001*

 Range

16.0–111.0

12.0–88.0

ALT (IU/L)

 Mean ± SD

60.5 ± 32.5

36.4 ± 17.1

^0.001*

 Range

11.0–132.0

18.0–76.0

Albumin (g/dL)

 Mean ± SD

3.7 ± 0.4

3.8 ± 0.4

^0.111

 Range

2.9–4.5

3.0–4.7

Total bilirubin (mg/dL)

 Mean ± SD

1.3 ± 0.5

1.4 ± 0.5

^0.303

 Range

0.4–2.1

0.3–2.3

Direct bilirubin (mg/dL)

 Mean ± SD

0.6 ± 0.2

0.7 ± 0.3

^0.165

 Range

0.1–1.1

0.1–1.1

Alkaline Ph. (mg/dL)

 Mean ± SD

76.6 ± 25.0

81.8 ± 29.1

^0.458

 Range

40.0–138.0

44.0–121.0

INR

 Mean ± SD

76.6 ± 25.0

81.8 ± 29.1

^0.111

 Range

40.0–138.0

44.0–121.0

  1. ^Independent t test
  2. #Chi square test
  3. *Significant